Medical Condition News

RSS

Boehringer Ingelheim receives European CHMP positive opinion for MICARDIS

Boehringer Ingelheim announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Evaluation Agency (EMEA) has issued a positive opinion for the approval of MICARDIS® (telmisartan) for the reduction of cardiovascular morbidity.

23 Oct 2009

Verizon Foundation awards $10,000 grant to The Wellness Community of the East Bay

The Wellness Community of the East Bay has been awarded a $10,000 grant from the Verizon Foundation, the philanthropic arm of Verizon, to fund the use of technology to identify the best community-based psychological and social support and education strategies for cancer patients and their families.

23 Oct 2009

Study shows appropriate use of CRRT improves AKI patient outcomes

A study appearing today in the New England Journal of Medicine adds to the growing body of evidence supporting continuous renal replacement therapy (CRRT) as the therapy of choice for treatment of acute kidney injury (AKI) patients in the intensive care unit (ICU).

23 Oct 2009

Number of diabetic patients on the rise; figures could reach to 440 million by 2030

Newly published data from the International Diabetes Federation (IDF) show that number of people with diabetes continues to grow unchecked. The figures reveal that, if action is not taken to change the path of the epidemic, the numbers of people with diabetes will be close to 440 million by 2030.

23 Oct 2009

Decision Resources predicts TNF-alpha inhibitors to dominate rheumatoid arthritis treatment

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to dominate first- and second-line biologic therapy for the treatment of rheumatoid arthritis in the United States through 2011, but the more established branded drugs such as, Centocor Ortho Biotech's Remicade, Abbott's Humira and Amgen/Wyeth's Enbrel, in this class will face competition from newer entrants.

23 Oct 2009

Community based initiative to help combat obesity and promote healthy lifestyles

President Bill Clinton made a special appearance on October 10 to open the Weight Watchers Presents Fun and Fit in the City -- at the Harlem Children's Zone in Harlem, NY. Part of the Food Network New York City Wine & Food Festival, the free community based initiative -- which drew over 800 attendees -- was created to help combat obesity and provide practical tips for families to follow healthier lifestyles.

23 Oct 2009

Vasamed partners with BBHOP for peripheral arterial disease research

On Saturday, November 7, 2009 Vasamed Inc., provider of diagnostic technologies that detect peripheral arterial disease in patients with diabetes, will partner with the Black Barbershop Health Outreach Program (BBHOP) in its mission to help African Americans identify the connection between peripheral arterial disease (PAD), diabetes, obesity and hypertension through early detection and referral to appropriate medical resources.

23 Oct 2009

Study: General anesthesia can cause brain injury in immature rats

Studies by researchers at Wake Forest University School of Medicine have shown that blocking the NMDA receptor in immature rats leads to profound, rapid brain injury and disruption of auditory function as the animals mature.

23 Oct 2009

Study reveals benefits of recombinant human C1 inhibitor in treating ischemic brain injury

Biotech company Pharming Group NV announced today publication of a preclinical study showing the benefit of using recombinant human C1 inhibitor (rhC1INH) in ischemic brain injury.

23 Oct 2009

Relationship between cannabis and schizophrenia is controversial

Last year the UK government reclassified cannabis from a class C to a class B drug, partly out of concerns that cannabis, especially the more potent varieties, may increase the risk of schizophrenia in young people. But the evidence for the relationship between cannabis and schizophrenia or psychosis remains controversial.

23 Oct 2009

Families of Spinal Muscular Atrophy and Repligen partner to develop a treatment for SMA

Families of Spinal Muscular Atrophy (FSMA) announced today that it has entered into a groundbreaking exclusive license agreement with Repligen Corporation for the development of a potential treatment of Spinal Muscular Atrophy (SMA).

23 Oct 2009

Brain inflammation not linked to Alzheimer's disease

In a surprising reversal of long-standing scientific belief, researchers at the Mayo Clinic campus in Florida have discovered that inflammation in the brain is not the trigger that leads to buildup of amyloid deposits and development of Alzheimer's disease.

23 Oct 2009

Study finds link between high levels of pesticide exposure and suicidal thoughts

A new study in China has found that people with higher levels of pesticide exposure are more likely to have suicidal thoughts. The study was carried out by Dr Robert Stewart from the Institute of Psychiatry at King's College London together with scientists from Tongde Hospital Zhejiang Province.

23 Oct 2009

Alzheimer's Association appreciates RCN for its generous donation and awareness campaign

RCN Corporation recently donated more than $10,000 towards the Alzheimer's Association, National Capital Area Chapter's Reflections campaign and the nonprofit's signature event, the National Memory Walk. Earlier in the year, the company committed $210,000 in donated cable time for cross-channel spots about local Alzheimer initiatives in 2009.

23 Oct 2009

Physicians' negative attitudes toward obese patients can affect quality of care

Doctors have less respect for their obese patients than they do for patients of normal weight, a new study by Johns Hopkins researchers suggests. The findings raise questions about whether negative physician attitudes about obesity could be affecting the long-term health of their heavier patients.

23 Oct 2009

New guidelines from American Academy of Dermatology for treatment of psoriasis with ultraviolet light therapy

Based on an extensive review of the highest quality scientific literature on psoriasis and the opinion of recognized psoriasis experts, the American Academy of Dermatology (Academy) has released new guidelines of care for the management and treatment of psoriasis with ultraviolet (UV) light therapy, also known as phototherapy. Recommendations for the use of the most common forms of UV light therapy, as stand-alone treatments or in conjunction with other therapies, were outlined, including patient considerations.

23 Oct 2009

Play less video games to keep your focus

Parents have long lectured their children about the mind-numbing effects of playing video games all day. And a new Iowa State University study has found that high volume action video game players -- those who play around 40 hours per week -- actually had more difficulty keeping focused on tasks requiring longer, more proactive attention than those who played video games less than a couple of hours a week.

23 Oct 2009

Canadian Cardiovascular Society to honor University of Alberta medical researcher

A University of Alberta medical researcher being hailed as a world leader in his field will receive a major national award for his pioneering work in the development of a new class of drugs for the treatment of heart failure.

23 Oct 2009

Liraglutide drug causes less nausea and hypoglycaemia compared to exenatide

New data on patient treatment satisfaction from the LEAD(TM) 6 trial presented on the 22nd October at the 20th World Diabetes Congress (International Diabetes Federation) shows that patients have higher overall treatment satisfaction with liraglutide than they do with exenatide.

23 Oct 2009

Intellectual property covering compounds that have utility in treating SMA licensed

Repligen Corporation announced today that it has entered into an exclusive license agreement with Families of Spinal Muscular Atrophy (FSMA) for intellectual property covering compounds which may have utility in treating Spinal Muscular Atrophy (SMA).

23 Oct 2009

Medical Condition News

Boehringer Ingelheim receives European CHMP positive opinion for MICARDIS

Verizon Foundation awards $10,000 grant to The Wellness Community of the East Bay

Study shows appropriate use of CRRT improves AKI patient outcomes

Number of diabetic patients on the rise; figures could reach to 440 million by 2030

Decision Resources predicts TNF-alpha inhibitors to dominate rheumatoid arthritis treatment

Community based initiative to help combat obesity and promote healthy lifestyles

Vasamed partners with BBHOP for peripheral arterial disease research

Study: General anesthesia can cause brain injury in immature rats

Study reveals benefits of recombinant human C1 inhibitor in treating ischemic brain injury

Relationship between cannabis and schizophrenia is controversial

Families of Spinal Muscular Atrophy and Repligen partner to develop a treatment for SMA

Brain inflammation not linked to Alzheimer's disease

Study finds link between high levels of pesticide exposure and suicidal thoughts

Alzheimer's Association appreciates RCN for its generous donation and awareness campaign

Physicians' negative attitudes toward obese patients can affect quality of care

New guidelines from American Academy of Dermatology for treatment of psoriasis with ultraviolet light therapy

Play less video games to keep your focus

Canadian Cardiovascular Society to honor University of Alberta medical researcher

Liraglutide drug causes less nausea and hypoglycaemia compared to exenatide

Intellectual property covering compounds that have utility in treating SMA licensed

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News